EMPAVELI DIN 02533294
Health Canada record
| Active ingredient(s) | PEGCETACOPLAN 1080 MG |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L04AJ03 PEGCETACOPLAN |
| Original market date | 15-Feb-2023 |
| Current status date | 15-Feb-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
Swedish Orphan Biovitrum AB — licence , not currently licensed, last inspection rating C (2022-03-17).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 29644 | 2022-12-08 | New Drug Submission (NDS) |